BioServe, NeoCodex Ink Co-Marketing Deal for Each Other's Tissue Banks | GenomeWeb
NEW YORK (GenomeWeb News) — Human tissue repository companies BioServe and NeoCodex have penned an agreement that will enable the firms to distribute each other’s products.
 
Terms of the deal give BioServe access to NeoCodex’s bio-repository of DNA, FFPE, fluid, and tissue samples collected from Spain’s "uniquely homogenous” population.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.